08/2026 – AstronDX Technologies has received regulatory approval for its new LyteStar™ TB-MDR PCR Kit, expanding the company’s molecular diagnostics portfolio for tuberculosis and antimicrobial resistance.
08/2026 – AstronDX Technologies has received regulatory approval for its new LyteStar™ TB-MDR PCR Kit, expanding the company’s molecular diagnostics portfolio for tuberculosis and antimicrobial resistance.